Causal relationship between elevated Lp(a) levels and CKD risk
Anne Langsted, MD, PhD
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
Pasquale Perrone-Filardi, MD, PhD
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Christie Ballantyne, MD
ANGPTL3 RNAi therapeutic lowers atherogenic lipids and lipoproteins in patients with mixed hyperlipidemia
Robert S. Rosenson, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.